Lidocaine-d10 hydrochloride

Modify Date: 2024-01-03 17:31:24

Lidocaine-d10 hydrochloride Structure
Lidocaine-d10 hydrochloride structure
Common Name Lidocaine-d10 hydrochloride
CAS Number 1189959-13-4 Molecular Weight 278.84800
Density N/A Boiling Point N/A
Molecular Formula C14H15ClD8N2O Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Lidocaine-d10 hydrochloride


Lidocaine-d10 (Lignocaine-d10) hydrochloride is the deuterium labeled Lidocaine hydrochloride. Lidocaine hydrochloride (Lignocaine hydrochloride) inhibits sodium channels involving complex voltage and using dependence[1]. Lidocaine hydrochloride decreases growth, migration and invasion of gastric carcinoma cells via up-regulating miR-145 expression and further inactivation of MEK/ERK and NF-κB signaling pathways. Lidocaine hydrochloride is an amide derivative commonly used to anesthetize. hydrochloride is a a drug to treat ventricular arrhythmia and an effective tumor-inhibitor[2].

 Names

Name Lidocaine-d10 hydrochloride
Synonym More Synonyms

 Lidocaine-d10 hydrochloride Biological Activity

Description Lidocaine-d10 (Lignocaine-d10) hydrochloride is the deuterium labeled Lidocaine hydrochloride. Lidocaine hydrochloride (Lignocaine hydrochloride) inhibits sodium channels involving complex voltage and using dependence[1]. Lidocaine hydrochloride decreases growth, migration and invasion of gastric carcinoma cells via up-regulating miR-145 expression and further inactivation of MEK/ERK and NF-κB signaling pathways. Lidocaine hydrochloride is an amide derivative commonly used to anesthetize. hydrochloride is a a drug to treat ventricular arrhythmia and an effective tumor-inhibitor[2].
Related Catalog
In Vitro Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
References

[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.

[2]. Cummins TR, et al. Setting up for the block: the mechanism underlying lidocaine's use-dependent inhibition of sodium channels. J Physiol. 2007 Jul 1;582(Pt 1):11.

[3]. Sui H, et al. Lidocaine inhibits growth, migration and invasion of gastric carcinoma cells by up-regulation of miR-145. BMC Cancer. 2019 Mar 15;19(1):233.

[4]. Li Z, et al. Evaluation of the antinociceptive effects of lidocaine and bupivacaine on the tail nerves of healthy rats. Basic Clin Pharmacol Toxicol. 2013 Jul;113(1):31-6.

 Chemical & Physical Properties

Molecular Formula C14H15ClD8N2O
Molecular Weight 278.84800
Exact Mass 278.20000
PSA 35.83000
LogP 4.03520

 Synonyms

2-[bis(pentadeuterioethyl)amino]-N-(2,6-dimethylphenyl)acetamide hydrochloride
2-(bis(perdeuterioethyl)amino)-N-(2,6-dimethylphenyl)acetamide hydrochloride